doosan robotics is a unit of the conglomerate have doosan.oosan robotics making its trading debut, korea's biggest listing of the year and one we will watch closely. doosan robotics provides collaborative robots. so, ones that do not just work on factory floors, but are designed to work outside of factories alongside humans. this is a company taking a look at financials. revenue steady since 2020. this is an industry, a career, really a leader in industrial automation and robotics in particular. you can see net income loss is starting to moderate. the company orderly expected to turn profitable by 2024. that is one of the big names we are watching at the top the next hour. as i said, korea's biggest listing this year. we have the opening of the asx 200 at the start of today's session. you can see it is just a snapping a three-day loss. because that is a very, very modest again we are seeing pretty much flat as we get underway. the big moves, continuingto track bond yields retreating somewhat. a big -- a bit of a reprieve echoing what came thr

. >>> shares of doosan robotics is higher on the first day of trade. the company's listing raised over 420 million, making its south korea's biggest ipo this year. >>> new era cap has reportedly chosen jpmorgan as the lead underwriter for an ipo next year. reuters has reported that the sports cap ipo could value as much as $500 billion. christoph boschan joins us now. great to have you in london. >> good morning. >>> it's great to have you on a day where we were preparing for this renk ipo on the market. everything changed this morning, the company decided to pull the ipo. cited an uncertain market environment. in your view do you companies should be nervous about listing in the current market environment? >> that decision is lies at the sole decision cession at the company. obviously, some companies see greater opportunity in the market, we've seen major fl floating recently. again, the window of opportunity. >> the arm listing was the most high profile to date, lots of hopes pin on that ipo going well and reopening the i. o market, do you think those

it has come off a it since the initial launch, but we are stl up some 97% from doosan robotics in seouly more ahead. this is bloomberg. ♪ nice footwork. man, you're lucky, watching live sports never used to be this easy. now you can stream all your games like it's nothing. yes! [ cheers ] yeah! woho! running up and down that field looks tough. it's a pitch. get way more into what you're into when you stream on the xfinity 10g network. nice footwork. man, you're lucky, watching live sports never used to be this easy. now you can stream all your games like it's nothing. yes! [ cheers ] yeah! woho! running up and down that field looks tough. it's a pitch. get way more into what you're into when you stream on the xfinity 10g network. rishaad: alright, there we go. let's have a look at assets in hong kong. we are of course seeing the rally, finally. developers on the way up. a bit ws being digested. coens with sumac which just a short while ago, about half an hour ago, it was given approval by a hong kong court for its debt restructuring of its dollar-denominateroads. h-sharear on the way up

it's doosan surgery and seizures and it sells for less than a dollar of file. it's been in shortage, on the shortage list for 15 years and it's pretty hard to buy an empty file for under a dollar. i think that illustrates stability in the market for a complex product that level. there are other drugs for nausea and cancer going for well under a dollar. it's not in shortage now but a price like that, there will be some they probably so it is relatively easy in one sense to predict shortage, the best predictor in the future is whether the drug shortage has been in the past so looking at the portfolio, which ones are low cost and which have been shortage in the past and a strong priority but we need to invest. >> thank you for the answer, appreciate it. one more minute. how has the generic drug market changed over the last five years. and you speak to generic drugs getting approved and marketed as well as recent bankruptcy announcements by companies? if you believe drug shortages are approving or getting worse over the next year or so. >> thank you for the questio